Vision Financial Markets’s AYTU BioPharma AYTU Stock Holding History

Vision Financial Markets’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5	Hold	2	–	–	﹤0.01%	409
2026 Q1	$6	Hold	2	–	–	﹤0.01%	422
2025 Q4	$6	Hold	2	–	–	﹤0.01%	406
2025 Q3	$4	Hold	2	–	–	﹤0.01%	429
2025 Q2	$5	Hold	2	–	–	﹤0.01%	433
2025 Q1	$3	Buy	+2	New	+$3	﹤0.01%	435

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vision Financial Markets's AYTU Position: Q2 2026 in Review

Vision Financial Markets held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 2 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #409.

Vision Financial Markets first reported a position in AYTU in Q1 2025 and has held it in 6 quarters since. The position peaked at $6 in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

Vision Financial Markets held 2 shares of AYTU BioPharma worth $5 as of Q2 2026.
Vision Financial Markets left its AYTU BioPharma share count unchanged in Q2 2026.
AYTU BioPharma made up ﹤0.01% of Vision Financial Markets's portfolio in Q2 2026, its #409 holding.
Vision Financial Markets first reported a position in AYTU BioPharma in Q1 2025 and has held it in 6 quarters since.
Vision Financial Markets's AYTU BioPharma position peaked at $6 in Q1 2026.
38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.